This joint meeting, hosted by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumour Immunology (EATI), and the American Association for Cancer Research (AACR), will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.

Entitled "Translating Science into Survival," this meeting will cover all areas of inquiry in cancer immunology and immunotherapy, including: immune regulation of T cell responsiveness, genomic methods for identifying tumour antigens, the tumour microenvironment, T cell therapies, checkpoint blockade, biomarkers, combinations, and the microbiome.

More than 60 talks by acknowledged leaders in these areas will be given.